Company: G
Filing Date: 2025-11-13
Form Type: 424B5
Source: 0001140361-25-041837
Chunk: 118

Company: Genpact LTD
Filing Date: 2025-11-13
Form: 424B5
Chunk 118
---
 its subsidiaries as of December 31, 2023 and 2024, and for each of the years in the three-year period ended December 31, 2024, and management’s assessment of the effectiveness of internal control over financial reporting as of December 31, 2024, have been incorporated by reference herein and in the registration statement in reliance upon the reports of KPMG Assurance and Consulting Services LLP, independent registered public accounting firm, incorporated by reference herein, and upon the authority of said firm as experts in accounting and auditing.

<div align='center'>S-75</div>

TABLE OF CONTENTS

PROSPECTUS Genpact Limited Debt Securities Guarantees of Debt Securities Common Shares Preference Shares Depositary Shares

| Genpact                       
 Luxembourg                    
 S.à r.l.                      |     | Genpact UK Finco plc          |     | Genpact USA, Inc. |
| Debt Securities               
 Guarantees of Debt Securities |     | Debt Securities               
 Guarantees of Debt Securities |     | Debt Securities   |

Warrants Units We may offer and sell the securities identified above from time to time in one or more offerings. This prospectus describes the general terms of these securities and the general manner in which these securities will be offered. We will provide the specific terms of these securities in supplements to this prospectus. The prospectus supplements will also describe the specific manner in which these securities will be offered and may also supplement, update or amend information contained in this document. You should read this prospectus and any applicable prospectus supplement before you invest. We may offer these securities in amounts, at prices and on terms determined at the time of offering. The securities may be sold directly to you, through agents, or through underwriters and dealers. If agents, underwriters or dealers are used to sell the securities, we will name them and describe their compensation in a prospectus supplement. Our common shares trade on The New York Stock Exchange under the symbol “G.” Investing in these securities involves certain risks. See “Risk Factors” included in any accompanying prospectus supplement and in the documents incorporated by reference in this prospectus for a discussion of the factors you should carefully consider before deciding to purchase these securities. Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense. The date of this prospectus is November 13, 2025

TABLE OF